Virano Therapeutics

Private

TorontoHealthcare & Life Scienceshttps://viranotx.com/

Last Round

Grant

Oct 23, 2025

Company Overview

Virano Therapeutics is a biotechnology company that develops genetic immunomodulation products and combination therapies to treat solid tumors and genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

genetic immunomodulationgene delivery systemsvector potentiatorsVEPOscombination therapygene therapybiotech R&Dsolid tumor treatmentgenetic disease therapydrug discoverybiotech licensingnext-gen gene therapypreclinical biotechtherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Virano Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Virano Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Virano Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 23, 2025
Accelerator	Dec 3, 2024
Seed	Nov 20, 2023

View all Funding Rounds

Virano Therapeutics Investors

Notable investors and investment history

Virano Therapeutics investors
Investor	Rounds
Ontario Bioscience Innovation Organization	Grant
Capital BioVentures	Accelerator, Seed
AyaWas Group	Seed
FACIT	Seed

View all Investors

Virano Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Virano Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Virano Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto

Employee Range1

Year Founded2021

Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.